Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application (Companion Animals, Livestock Animals, Wildlife Animals), By Region, And Segment Forecasts, 2025 - 2030

Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application (Companion Animals, Livestock Animals, Wildlife Animals), By Region, And Segment Forecasts, 2025 - 2030

Rabies Veterinary Vaccines Market Growth & Trends

The global rabies veterinary vaccines market size is expected to reach USD 1.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2025 to 2030. The key factors driving the market include an increase in zoonotic disease awareness, boosting stray animal immunization coverage, and growing number of government initiatives with the motive of eradicating rabies by 2030. One of the main drivers propelling the market for animal rabies vaccinations is domestic animal vaccine awareness and education. There are numerous vaccines approved for use in domestic animal species, which include inactivated and modified-live virus vector products, products for IM and SC injection, products with immunization durations ranging from 1 to 3 years, and products with a range of minimum vaccination ages. Regular public education, responsible pet ownership, routine veterinary treatment and vaccinations, and continuous professional training are crucial elements of rabies prevention and control. By spreading knowledge about rabies transmission channels, the necessity of avoiding contact with wildlife and vaccinating wildlife with bait rabies vaccines are widely initiated, which greatly helps in reducing the spread of the disease from wildlife sources. Additionally, the vaccination improves domestic animals’ general health and is linked to a decline in all-cause mortality rates.

Rabies is a deadly disease that attacks the central nervous system and has no effective treatment once clinical signs appear. It is estimated that 8.6 million dollars are spent globally on canine rabies, which is responsible for 98% of approximately 60,000 total rabies deaths that occur each year. The U.S. has made enormous efforts over the past 50 years to eradicate rabies in both animal and human populations. The number of animals infected with canine-mediated rabies has decreased from up to 10,000 cases per year because of the development of mass animal vaccination procedures and the enforcement of leash restrictions. Despite these developments, rabies continues to pose a major threat to public health and is still prevalent in raccoons, skunks, and foxes in wildlife reservoirs throughout the U.S.

All around the world, the COVID-19 pandemic has disrupted crucial health services. The United Against Rabies Forum, which advocates a ‘One Health’ strategy, was established in 2020 to hasten the achievement of this objective. The main components of the global rabies strategy include community involvement, better access to human rabies vaccines, and expanded mass dog vaccination. The advancement of rabies eradication strategies can be used as a marker for the equity of healthcare access in underserved populations and as an early indicator for the successful implementation of ‘One Health’. The core element of the global rabies elimination strategy is mass dog vaccination, with a 70% coverage rate as the goal. The majority of endemic nations saw difficulties with distribution, volume reductions, and importation delays for dog vaccines. This was because dog vaccines initially did not fit within the category of necessary items. Budget restrictions prevented the production of dog vaccines even in countries such as Zambia where they are made locally.

Rabies is spread through saliva, which means the infection can be transmitted through infected animal bites. Rabies can be transmitted by monkeys, dogs, bats, or, in some cases, cats. 98% of rabies cases in Indonesia are caused by rabid dog bites. According to an article published in December 2021, by the National Library of Medicine over the past 10 years, there has been a slight increase in the number of animal rabies cases globally. In Thailand, a study was conducted between 2017 and 2018 to identify the characteristics of animal rabies, assess the relationship between monthly rabies incidence and understandable factors using generalized additive models, and estimate the geographical risk areas for rabies spread. According to the study, dogs are the most common species in Thailand that are infected by rabies. The majority of the infected dogs were owned, roaming freely, and were not vaccinated. The northeast region of the country has the highest concentrations of rabies cases, followed by the middle and southern regions. In the short term, the number of cases increased gradually after June and significantly from January in 2018. Such rabies-endemic countries are taking strong measures such as dog mass vaccination programs, wildlife bait rabies vaccination campaigns, and mandatory pet rabies vaccinations among others, which are anticipated to fuel the growth of the market.

Rabies Veterinary Vaccines Market Report Highlights

• The companion animals segment held the largest revenue share in 2024 owing to the mandatory pet rabies vaccinations regulated in several countries, largely conducted mass dog vaccination programs, and significantly rising dog ownership rates
• The wildlife animals segment is anticipated to expand at the fastest CAGR of 4% over the forecast period owing to the rising wildlife rabies vaccination campaigns in developed regions
• North America is expected to maintain its lead over the forecast period. This is due to the region’s high per capita animal healthcare spending and a large number of pet ownership rates. Almost every state in the U.S. mandates regular rabies vaccination for pets with the mission of eradicating rabies in the near future

Please note The report will be delivered in 2-3 business days upon order notification.